MDAIMDAIHealthcare · Medical Devices

MDAI Stock Forecast: Spectral AI, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$1.04
−20.61% on the day

The median 12-month analyst price target for Spectral AI, Inc. is $5.09. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 26 of 100 as at 21 Nov 2026 — in the lower half.

Market cap
$33.5M
Ticker Nerd rank
26/ 100
Median analyst target
$5.09
Analysts covering
1
Revenue$3.5M−30.4% y/y
Operating income−$4.3M
Net income−$4.2M
Free cash flow−$4.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−20.0%
1M
−31.1%
YTD
−26.8%
1Y
−24.6%
From 52W high
−61.2%
From 52W low
0.0%
$1.04
$2.68
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Spectral AI, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
26/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Revisions
64
Growth
51
Volatility
47
Quality
37
Value
29
Momentum
27
Accruals
22
Issuance
6

Revisions (64): Analysts have, on balance, been raising their forecasts.

Issuance (6): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

MDAI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MDAI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$2.00$3.00$4.00$5.00$6.00$7.00Jan 26Apr 26Jul 26Oct 26MDAIHigh $6.25Median $5.09Low $4.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts
1
Buy
0
Hold
0
Sell
$4.00
Low
$5.09
Median
$6.25
High
Recent analyst actionsNewest first
DateFirmActionRatingTarget
27 May 2026BTIGMaintainsBuy$3.00 → $4.00
26 May 2026BTIGMaintainsBuy$3.00 → $4.00
25 Mar 2026BTIGReiteratesBuy—
10 Feb 2026BTIGReiteratesBuy—
12 Nov 2025BTIGMaintainsBuy—
2 Apr 2025HC Wainwright & Co.ReiteratesBuy—
18 Mar 2025HC Wainwright & Co.ReiteratesBuy—
13 Aug 2024HC Wainwright & Co.ReiteratesBuy—
12 Aug 2024Northland Capital MarketsInitiatesOutperform—
18 July 2024HC Wainwright & Co.InitiatesBuy—
23 Jan 2024BTIGInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for MDAI.

Market Radar

This page is one stock. Monday covers all of them.

MDAI appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

MDAI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Spectral AI, Inc. returned −24.6% against +6.9% for the S&P 500, dividends included.

MDAI vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200Jan 26Apr 26Jul 26Oct 26MDAIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

MDAI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
2.3×

Cheaper than 44% of US stocks

Price / book
—
EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
31.6%

Higher than 36% of US stocks

Operating margin
−86.5%

Higher than 15% of US stocks

Net margin
−70.5%

Higher than 8% of US stocks

Returns & dividend
Return on equity
—
Return on assets
−49.1%

Higher than 8% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Spectral AI, Inc. has a market value of $33.5M and an enterprise value of $38.9M.

  • Revenue in the twelve months to 30 June 2026: $15.4M. The latest quarter shrank 30.4% year on year.

  • Net income over the same four quarters: −$10.1M, a −65.5% net margin.

  • Diluted earnings per share, trailing twelve months: −$0.35.

  • Free cash flow in the twelve months to 30 June 2026: −$12.9M.

  • Shares outstanding: 32.2M.

  • Spectral AI, Inc. employs 65 people — $237K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

MDAI and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
MDAISpectral AI, Inc.$33.5M26
MYOMyomo, Inc.$32.1M62
TELATELA Bio, Inc.$31.1M36
RPIDRapid Micro Biosystems, Inc.$36.6M36
SRTSSensus Healthcare, Inc.$37.2M50
XTNTXtant Medical Holdings, Inc.$29.5M51
NSYSNortech Systems, Inc.$29.4M82

Take a look at MDAI’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Spectral AI, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about MDAI

What is the MDAI stock price forecast for 2026-2027?

The median 12-month analyst price target for Spectral AI, Inc. is $5.09, with estimates ranging from $4 to $6.25. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is MDAI stock a buy right now?

Of the 1 analyst covering Spectral AI, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Spectral AI, Inc. 26 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MDAI?

As at 21 Nov 2026, Spectral AI, Inc. ranks 26 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Revisions (64 of 100).

Will MDAI stock go up?

No one can know that. What the data says: the median 12-month target from 1 analyst is $5.09, and Ticker Nerd's factor model ranks Spectral AI, Inc. 26 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the MDAI stock forecast for 2030?

No analyst covering Spectral AI, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MDAI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $4 to $6.25 over the next 12 months.

How has MDAI stock performed over the past year?

Spectral AI, Inc. returned -24.6% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Spectral AI, Inc. do?

Spectral AI Inc. Class A Common Stock represents Spectral AI Inc., an artificial intelligence company focused on predictive medical diagnostics for wound care. The company’s DeepView platform is designed to help clinicians assess wound healing potential before treatment by using proprietary AI and multispectral imaging to distinguish between damaged and healthy tissue.

Company

About Spectral AI, Inc.

Spectral AI Inc. Class A Common Stock represents Spectral AI Inc., an artificial intelligence company focused on predictive medical diagnostics for wound care. The company’s DeepView platform is designed to help clinicians assess wound healing potential before treatment by using proprietary AI and multispectral imaging to distinguish between damaged and healthy tissue. Its current work centers on supporting faster, more objective treatment decisions in burn care and diabetic foot ulcer applications, with additional clinical uses in development. Spectral AI serves the healthcare technology market by combining imaging, software, and diagnostic analysis into tools intended for physician use in hospital and clinical settings. Headquartered in Dallas, Texas, Spectral AI operates as a specialized medical technology business within the broader digital health and medical devices sector.

CEO Mr. Vincent Stanley Capone Esq. · 65 employees · United States · https://www.spectral-ai.com